Dozens of illnesses have been linked to possibly contaminated injections of a peptide called glutathione, according to federal health officials. Some people have been hospitalized. The Food and Drug ...

Add Yahoo as a preferred source to see more of our stories on Google. -Credit:Reach Publishing Services Limited Almost half of people who discontinue injectable weight-loss medicines cite cost or ...

A WOMAN died from a life-threatening allergic reaction after she was given a steroid injection at her GP surgery, an inquest has found. June Turner, from north London, attended the clinic on September ...

Sept 17 (Reuters) - Xenon Pharmaceuticals (XENE.O), opens new tab on Thursday said it has temporarily paused enrolling new patients in clinical studies testing its experimental drug for ‌major and ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. GLP-1 medications like Ozempic are known for common side effects such as nausea, vomiting ...

Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics. Renée previously worked as senior pet ...

Maybe your doctor has mentioned them, a friend or family member is taking one — or a growing list of related drugs. The dramatic before-and-after stories of weight loss are everywhere, but so are the ...

The quest to identify a new way to potentially counter one of the world's most widely discussed solar geoengineering proposals has taken a new, exciting turn—raising questions about how future climate ...

Mayim Bialik is speaking out candidly about a severe reaction she says she experienced after taking a GLP-1 medication, revealing that a single low-dose injection led to weeks of debilitating ...

(NEXSTAR) – GLP-1 drugs, which have grown incredibly popular in recent years for their ability to help people lose substantial weight, are now friendlier to needle-phobes. The class of medications, ...

NEW YORK, June 6 (Reuters) - Pfizer (PFE.N), opens new tab presented data on Saturday that showed a monthly dose of an experimental obesity drug it acquired through ‌its purchase of Metsera last year ...

Bialik detailed her experience with a weight-loss drug in a personal essay, saying the reaction left her needing IV fluids and unable to keep food down Angelique Brenes is a writer-reporter at PEOPLE.